Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nuremberg
Clinical trial register · Germany

Clinical Trials in Nuremberg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC5 AstraZeneca4 Novartis Pharmaceuticals3 University Hospital, Basel, Switzerland3 Bristol-Myers Squibb3
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Nuremberg

69 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors
NCT07762820Bladder Cancer, Bladder Cancer TNM Staging Primary Tumor (T) T1
Ludwig-Maximilians - University of Munich
Not applicable
75
Augsburg, Erlangen, Munich, Nuremberg
2026-09-01
Not yet open
iVascular S.L.U.
Not applicable
160
Bremen, Cologne, Dortmund, Hamburg, Nuremberg
2026-05-31
Recruiting
Dr. Gerhard Mann chem.-pharm. Fabrik GmbH
Not applicable
160
Freiburg im Breisgau, Heidelberg, Tübingen, Munich, Nuremberg, Prien am Chiemsee, Ahaus, Brühl
2026-04-30
Recruiting
Wuerzburg University Hospital
Not applicable
200
Würzburg, Erlangen, Hamburg, Hattingen, Marburg, Nuremberg
2026-04-10
Recruiting
Targeting Real World Usage In Stroke Treatment
NCT07474935Saccular and Fusiform Aneurysms, Pseudoaneurysm, Vascular Dissection, Perforation
Phenox GmbH
Observational
5,000
Erfurt, Hamburg, Heidelberg, München, Nuremberg
2026-01-29
Recruiting
University of Cologne
Phase 3
420
Stuttgart, Nuremberg, Aachen, Berlin, Cologne, Dortmund, Dresden, Düsseldorf
2025-12-16
Recruiting
One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy
NCT07052045Stroke Acute, Acute Ischemic Stroke AIS, Hemorrhagic Stroke, Intracerebral
Prof. Dr. Jan Liman
Not applicable
390
Nuremberg
2025-12-02
Recruiting
Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings
NCT07508007Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice
Novartis Pharmaceuticals
Observational
4,500
Nuremberg
2025-11-28
Recruiting
iVascular S.L.U.
Not applicable
57
Bonn, Kiel, Marburg, Nuremberg, Recklinghausen
2025-11-27
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Heidelberg, Nürtingen, Munich, Nuremberg, Regensburg, Hanover, Kiel, Jena
2025-09-30
Active, closed
Support C Post-Market Registry
NCT06678490Coronary Arteriosclerosis
OrbusNeich
Observational
282
Erfurt, Hagen, Lahr, Nuremberg
2025-07-09
Not yet open
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
NCT06929468Ototoxic Hearing Loss, Ototoxicity, Drug-Induced, Cisplatin-induced Hearing Loss, Cisplatin Ototoxicity
Simon Jäger
Observational
55
Nuremberg
2025-07
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Berlin, Essen, Frankfurt am Main, Hanover, Leipzig, Mainz, Munich, Nuremberg
2025-05-22
Recruiting
Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair
NCT06332911Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture, Abdominal Aortic Aneurysm Without Rupture, Thoracic Aortic Aneurysm Without Rupture
Rede Optimus Hospitalar SA
Observational
30
Münich, Nuremberg
2025-05-19
Recruiting
Risk Factors for Neuroendocrine Neoplasms
NCT06282016Neuroendocrine Neoplasm of Lung, Neuroendocrine Neoplasm of Gastrointestinal Tract (Disorder)
Bavarian Cancer Registry
Observational
14,250
Nuremberg
2025-05-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Nürtingen, Stuttgart, Munich, Nuremberg, Potsdam, Frankfurt am Main, Cologne, Duisburg
2025-05-13
Recruiting
Daiichi Sankyo
Phase 3
510
Berlin, Bonn, Dresden, Frankfurt am Main, Hamburg, Jena, Leipzig, Nuremberg
2025-03-27
Recruiting
University of Erlangen-Nürnberg Medical School
Not applicable
127
Nuremberg
2025-03-12
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
DrugRapcabtagene autoleucel
Novartis Pharmaceuticals
Phase 2
21
Cologne, Leipzig, Jena, Aachen, Hamburg, Mainz, Nuremberg, Ulm
2024-12-17
Active, closed
AstraZeneca
Phase 3
768
Berlin-Zehlendorf, Essen, Georgsmarienhütte, Großhansdorf, Hamburg, Löwenstein, Nuremberg
2024-10-04
Recruiting
Bayer
Phase 3
444
Stuttgart, Nuremberg, Frankfurt am Main, Giessen, Cologne, Essen, Hemer, Berlin
2024-08-28
Recruiting
Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
NCT07515508Cardiogenic Shock, Acute Heart Failure (AHF)
University Heart Center Freiburg - Bad Krozingen
Observational
600
Bad Krozingen, Freiburg im Breisgau, Nuremberg, Villingen-Schwenningen
2024-08-07
Recruiting
Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial
NCT07137260Pulmonary Hypertension, Precapillary Pulmonary Hypertension, Right Heart Catheterisation, Digital Mobility Outcomes
Simon Jäger
Observational
77
Stuttgart, Munich, Nuremberg, Löwenstein
2024-04-19
Recruiting
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
NCT06134492Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia, Herpes Simplex
DrugAcyclovir
Jena University Hospital
Phase 3
616
Freiburg im Breisgau, Heidelberg, Tübingen, Augsburg, München, Nuremberg, Regensburg, Rosenheim
2024-02-20
Recruiting
Pfizer
Phase 3
492
Freiburg im Breisgau, Stuttgart, Ulm, Nuremberg, Bonn, Berlin, Cottbus, Hamm
2024-02-08
Recruiting
Janssen-Cilag Ltd.
Observational
900
Chemnitz, Dresden, Hamburg, Hanover, Heidelberg, Nuremberg, Würzburg
2023-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
München, Nuremberg, Marburg, Hanover, Moers, Münster, Mainz, Großhansdorf
2023-12-15
Recruiting
AstraZeneca
Phase 1/2
226
Essen, Freiburg im Breisgau, Hamburg, Heidelberg, Lübeck, Nuremberg, Tübingen, Würzburg
2023-12-05
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
188
Berlin-Spandau, Darmstadt, Hamburg, Heidelberg, Nuremberg
2023-11-20
Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
NCT06128551Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
DrugsElironrasib·Cetuximab
Revolution Medicines, Inc.
Phase 1/2
534
Cologne, Esslingen am Neckar, Moers, Nuremberg
2023-11-14
Active, closed
Celgene
Phase 3
79
Heidelberg, Ulm, Nuremberg, Cologne, Leipzig, Dresden, Essen, Hamburg
2023-10-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Bad Friedrichshall, Heidelberg, Mannheim, Nuremberg, Wallerfing, Bad Nauheim, Frankfurt am Main, Hanover
2023-10-09
Not yet open
SURgical Registry of ENDocarditis EuRope
NCT05563662Infective Endocarditis, Cardiac Surgery, Outcomes
University Hospital, Essen
Observational
10,000
Nuremberg, Essen
2023-09
Active, closed
Novartis Pharmaceuticals
Observational
436
Freiburg im Breisgau, Rheinstetten, Haßfurt, Kulmbach, Lauf an der Pegnitz, Nuremberg, Panketal, Hamburg
2023-08-10
Recruiting
IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors
NCT05958121Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Immatics Biotechnologies GmbH
Phase 1/2
400
Heidelberg, Mannheim, Tübingen, Ulm, Erlangen, Nuremberg, Regensburg, Würzburg
2023-08-09
Recruiting
University Hospital, Basel, Switzerland
Not applicable
280
Bochum, Düsseldorf, Erlangen, Essen, Frankfurt, Freiburg im Breisgau, Ludwigshafen am Rhein, Nuremberg
2023-07-14
Recruiting
European Aortic Data Collection Project
NCT05896397Complex Abdominal Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm, Chronic Aortic Dissection
Cook Research Incorporated
Observational
600
Hamburg, Munich, Münster, Nuremberg
2023-05-31
Recruiting
The DefiPace Study
NCT04804748Post-operative Atrial Fibrillation POAF
Institut für Pharmakologie und Präventive Medizin
Observational
450
Erlangen, Nuremberg, Würzburg, Oldenburg, Dresden, Freiburg im Breisgau, Hanover, Jena
2023-03-28
Recruiting
University Hospital, Basel, Switzerland
Observational
1,000
Berlin, Frankfurt, Hamburg, Kiel, Krefeld, Nuremberg, Reinbek, Sindelfingen
2022-12-16
Recruiting
Regeneron Pharmaceuticals
Observational
500
Konstanz, Weinsberg, München, Nuremberg, Georgsmarienhütte, Rotenburg (Wümme), Münster, Troisdorf
2022-10-26
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Berlin, Essen, Halle, Hamburg, Nuremberg, Tübingen, Würzburg
2022-10-25
Active, closed
APPETITE: Plant Protein and Exercise Solutions for the Prevention of Undernutrition in Older Adults.
NCT05608707Appetite Loss, Physical Inactivity, Undernutrition, Anorexia of Aging
University College Dublin
Not applicable
180
Nuremberg
2022-09-22
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Hamburg, Heidelberg, Jena, Lübeck, München, Nuremberg, Tübingen, Würzburg
2022-09-08
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Mannheim, Tübingen, Munich, Nuremberg, Regensburg, Frankfurt am Main, Giessen, Buxtehude
2022-07-14
Active, closed
Sanofi
Phase 3
531
Dresden, Heidelberg, Lübeck, Nuremberg
2022-06-23
Active, closed
Immatics Biotechnologies GmbH
Phase 1
95
Freiburg im Breisgau, Heidelberg, Tübingen, Ulm, Erlangen, Munich, Nuremberg, Regensburg
2022-05-19
Active, closed
Boston Scientific Corporation
Not applicable
500
Bonn, Nuremberg
2021-12-21
Active, closed
AbbVie
Observational
634
Freiburg im Breisgau, Heidelberg, Langenau, Stuttgart, Freising, Memmingen, Munich, Nuremberg
2021-12-13
Recruiting
Corcym S.r.l
Observational
2,150
Augsburg, Bad Nauheim, Berlin, Dresden, Essen, Magdeburg, Nuremberg, Oldenburg
2021-06-29
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Freiburg im Breisgau, Heidelberg, Nuremberg, Frankfurt am Main, Aachen, Homburg/ Saar, Halle, Erfurt
2021-02-25
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Cologne, Duisburg, Herne, Markkleeberg, Mettmann, Münster, Nuremberg, Nürtingen
2020-12-18
Active, closed
Pfizer
Observational
1,407
Bayreuth, Nuremberg, Cottbus, Goslar, Bonn, Bad Mergentheim, Berlin, Bremen
2020-10-27
Active, closed
BGP+ Stent as Bridging Stent in BEVAR
NCT03982940Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture
Marc Bosiers, MD
Not applicable
118
Heidelberg, Kiel, Aachen, Hamburg, Leipzig, Munich, Münster, Nuremberg
2020-09-09
Active, closed
AstraZeneca
Phase 3
1,012
Berlin, Duisburg, Hamburg, Herne, Mettmann, Münster, Nuremberg, Nürtingen
2020-07-13
Active, closed
University of Leipzig
Not applicable
5,227
München, Nuremberg, Bremen, Leipzig, Berlin, Altenburg, Aschaffenburg, Augsburg
2020-07-07
Active, closed
Adipositas Care & Health Therapy
NCT04768127Patients After Metabolic-bariatric Surgery, Obesity, Morbid
Wuerzburg University Hospital
Not applicable
586
Gräfelfing, Memmingen, München, Nuremberg, Offenbach, Passau, Würzburg
2020-05-15
Active, closed
Institut für Pharmakologie und Präventive Medizin
Observational
500
Nuremberg, Passau, Würzburg, Frankfurt am Main, Oldenburg, Aachen, Bad Rothenfelde, Bochum
2019-12-12
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
NCT04065399Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Lineage Acute Leukemia, Mixed Phenotype Acute Leukemia
DrugsCobicistat·Revumenib
Syndax Pharmaceuticals
Phase 1/2
447
Ulm, Essen, Greifswald, Gutenberg, Hamburg, Leipzig, Nuremberg
2019-11-05
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Löwenstein, Munich, Nuremberg, Essen, Aachen, Berlin, Buxtehude, Cologne
2019-08-09
Active, closed
IMPEDE and IMPEDE-FX Embolization Plug Registry
NCT04044443Peripheral Vascular Embolization
Shape Memory Medical, Inc.
Observational
108
Dresden, Heidelberg, Kiel, Leipzig, München, Nuremberg, Stuttgart, Würzburg
2019-07-09
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Leipzig, Nuremberg
2019-05-09
Recruiting
Perioperative Management Evaluation in Patients With CIED
NCT04331249Cardiac Pacemaker Malfunction, ICD Malfunction, Cardiac Pacemaker Electrical Interference, Anesthesia Complication
Klinikum-Fuerth
Observational
500
Fürth, Nuremberg
2018-11-27
Active, closed
AstraZeneca
Phase 3
895
Bergisch Gladbach, Bremen, Cologne, Duisburg, Freiburg im Breisgau, Heinsberg, Mettmann, Nuremberg
2018-10-31
Active, closed
IRCCS San Raffaele
Observational
200
Nuremberg, Hamburg, Münster
2018-10-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Mannheim, Tübingen, Munich, Nuremberg, Würzburg, Buxtehude, Hanover, Essen
2018-09-12
Active, closed
Bristol-Myers Squibb
Phase 3
1,314
Dresden, Essen, Freiburg im Breisgau, Hamburg, Hanover, Jena, Mannheim, Nuremberg
2017-03-24
Active, closed
RWTH Aachen University
Phase 2
207
Mannheim, Ulm, Winnenden, Aschaffenburg, Müchen, Nuremberg, Hamburg, Mainz
2015-10
Active, closed
Eli Lilly and Company
Phase 3
453
Berlin, Gera, Großhansdorf, Hamburg, Hanover, Heidelberg, Immenhausen, Nuremberg
2014-10-03
Active, closed
University Hospital, Basel, Switzerland
Observational
3,500
Nuremberg
2010-04
Rows per page Showing 1–69 of 69
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/nuremberg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 69 of those studies with a site in Nuremberg.

How many clinical trials are recruiting in Nuremberg?

36 of the 69 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 4 have not yet opened recruitment, 29 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nuremberg), 69 studies
PhaseStudiesRecruitingShare
Observational231333.3%
Phase 3211030.4%
Not applicable14720.3%
Phase 2517.2%
Phase 1/2445.8%
Phase 1101.4%
Phase 2/3111.4%

Most active sponsors

Lead sponsors with the most studies (Nuremberg)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC52
AstraZeneca41
Bristol-Myers Squibb32
Novartis Pharmaceuticals31
University Hospital, Basel, Switzerland32
Immatics Biotechnologies GmbH21
Institut für Pharmakologie und Präventive Medizin21
iVascular S.L.U.21
Janssen Research & Development, LLC21
Pfizer21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.